BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Drug Development

  Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1

  November 28, 2011

   · 

  6 min read
• BioCapital

  USPTO Denies Request for Reexamination of Butamax Pioneering Patent and Orders Limited Reexamination of Butamax Second Patent

  November 28, 2011

   · 

  2 min read
• Deals

  Axolabs GmbH Completes Management Buy-Out of Former Roche Center of Excellence in Kulmbach

  November 28, 2011

   · 

  1 min read
• Policy

  Takeda Pharmaceutical Co. Ltd. Submits New Drug Application in the U.S. for Investigational Type 2 Diabetes Therapy, Fixed-Dose Combination Alogliptin/Metformin

  November 28, 2011

   · 

  4 min read
• BioMidwest

  Spectrum Pharmaceuticals, Inc. to Ring the Nasdaq Stock Market Opening Bell on Tuesday, November 29, 2011

  November 28, 2011

   · 

  1 min read
• Business

  Drug Safety and Preclinical Sciences Leader Joins MPI Research

  November 28, 2011

   · 

  1 min read
• Genetown

  Ariad Pharmaceuticals, Inc. to Present at the 2011 Deutsche Bank BioFEST

  November 28, 2011

   · 

  1 min read
• BioForest

  IsoRay, Inc. Ships First GliaSite® Brain Cancer Treatment

  November 28, 2011

   · 

  1 min read
• Mindray Medical to Hold Annual General Meeting in Hong Kong on December 19, 2011

  November 28, 2011

   · 

  1 min read
• Moleac Announces the Launch of NurAiD II in France, a “Recovery Stimulator” Marketed as a Natural Food Supplement

  November 28, 2011

   · 

  3 min read